1. Home
  2. XBP vs ECOR Comparison

XBP vs ECOR Comparison

Compare XBP & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XBP

XBP Europe Holdings Inc.

N/A

Current Price

$2.55

Market Cap

47.0M

ML Signal

N/A

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.55

Market Cap

48.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
ECOR
Founded
N/A
2005
Country
United States
United States
Employees
10998
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
48.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
XBP
ECOR
Price
$2.55
$6.55
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$18.00
AVG Volume (30 Days)
13.9K
56.6K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$32,032,000.00
Revenue This Year
$2.59
$33.60
Revenue Next Year
$5.75
$30.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.20
52 Week Low
$0.41
$4.16
52 Week High
$8.55
$8.30

Technical Indicators

Market Signals
Indicator
XBP
ECOR
Relative Strength Index (RSI) 46.72 55.92
Support Level $2.50 $4.61
Resistance Level $8.46 $7.35
Average True Range (ATR) 0.36 0.54
MACD 0.07 -0.01
Stochastic Oscillator 69.00 62.20

Price Performance

Historical Comparison
XBP
ECOR

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. By combining innovation with execution excellence, XBP Global helps businesses reimagine business process automation and enable digital transformation.

About ECOR electroCore Inc.

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Share on Social Networks: